Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Medica Weight Loss
WARNING LETTER
•Medica Weight Loss•March 1, 2026

Medica Weight Loss – FDA Warning Letter, Mar 1, 2026

Record Details

On June 8, 2026, the FDA issued a warning letter to Medica Weight Loss following a March 2026 review of the company’s website. The agency identified several significant violations concerning the promotion of compounded drug products, specifically semaglutide and tirzepatide. Under the regulatory framework of the Federal Food, Drug, and Cosmetic Act, the FDA determined these products are misbranded due to false and misleading claims. Primary issues included labels that suggested Medica Weight Loss was the manufacturer when they were not, as well as claims that the compounded drugs were FDA-approved. The FDA emphasized that compounded medications do not undergo the agency"s pre-market review for safety and effectiveness. Furthermore, the company incorrectly claimed to use an "FDA-approved pharmacy," a designation that does not exist under federal law. Medica Weight Loss is required to investigate the root causes of these violations and implement corrective actions. They must submit a written response to the FDA within 15 business days outlining the steps taken to address the misleading claims and identify the actual entities producing the drugs. Failure to correct these issues may result in legal actions such as product seizures or injunctions.

Company
Medica Weight Loss
Inspection date
March 1, 2026
Product type
drugs
Office
Center for Drug Evaluation and Research
Person
  • Matthew J. Lash (Acting Director)
View Company Profile

ID · d4a8e8bc-5cf8-49db-8bff-2b24e2029385

Violation Codes10
FD&C Act 502(a)FD&C Act 502(bb)21 U.S.C. 352(a)21 U.S.C. 352(bb)FD&C Act 301(a)21 U.S.C. 331FD&C Act 301(c)21 U.S.C. 331(c)FD&C Act 503AFD&C Act 503B

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medica Weight Loss
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.